Fortress Biotech
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Fortress Biotech's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12% to $84,513,000. The net income raised on -$60,637,000 and profit margin reached -72%. Total operating expenses were $200,195,000.
Profit Margin
| 2014 | 0 | -20.38M | |
|---|---|---|---|
| 2015 | 863K | -48.42M | -5611.59% |
| 2016 | 16.48M | -55.09M | -334.31% |
| 2017 | 187.58M | -66.87M | -35.65% |
| 2018 | 26.88M | -84.14M | -313.02% |
| 2019 | 36.62M | -51.80M | -141.44% |
| 2020 | 45.59M | -102.98M | -225.85% |
| 2021 | 68.79M | -164.82M | -239.6% |
| 2022 | 75.74M | -213.91M | -282.42% |
| 2023 | 84.51M | -60.63M | -71.75% |
FBIO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 84.51M | 75.74M | 68.79M | 45.59M | 36.62M | 26.88M | 187.58M | 16.48M | 863K | 0 |
Cost of revenue | 26.66M | 30.77M | 32.08M | 14.59M | 10.53M | 6.12M | 161.20M | 11.34M | 0 | 0 |
Gross profit | 57.85M | 44.96M | 36.70M | 31.00M | 26.09M | 20.75M | 26.38M | 5.13M | 863K | 0 |
Operating exp. | ||||||||||
Research and development | 106.07M | 134.87M | 128.86M | 64.10M | 81.32M | 87.38M | 52.48M | 35.13M | 29.81M | 10.23M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 155.18M | 10.41M | 0 | 0 |
Total operating expenses | 200.19M | 247.22M | 215.70M | 125.27M | 136.91M | 140.75M | 127.59M | 70.84M | 51.39M | 20.65M |
Operating income | -142.34M | -202.26M | -179.00M | -94.27M | -110.81M | -119.99M | -101.20M | -65.71M | -50.53M | -20.65M |
Other income (expenses), net | -11.29M | -11.20M | 14.64M | -8.57M | 9.15M | -1.56M | -7.71M | -2.18M | -3.35M | 266K |
Income before tax | -153.63M | -213.46M | -164.35M | -102.84M | -101.66M | -130.8M | -98.32M | -71.29M | -53.88M | -20.38M |
Income tax expense | 521K | 449K | 473K | 136K | -49.85M | -463K | 1.51M | -12.50M | -3.99M | 1.31M |
Net income | -60.63M | -213.91M | -164.82M | -102.98M | -51.80M | -84.14M | -66.87M | -55.09M | -48.42M | -20.38M |
Earnings per share | ||||||||||
Basic EPS | -8.47 | -36.1 | -30.26 | -21.45 | -14.2 | -29.04 | -24.08 | -20.68 | -18.56 | -8.42 |
Diluted EPS | -8.47 | -36.1 | -30.26 | -21.45 | -14.2 | -29.04 | -24.08 | -20.68 | -18.56 | -8.42 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |